van Kaam 1998.
Methods | Blinding of randomisation: yes Blinding of intervention: can't tell but probably impossible Complete follow‐up: no Blinding of outcome measurement: can't tell | |
Participants | Premature infants, <2000g. Haemolysis excluded. Qualifying SBR determined by age and birthweight from graphs. Fibreoptic n=56, conventional n=68. | |
Interventions | Fibreoptic: BiliBlanket at 35 microwatts/cm2/nm (measured). Convnetional: White light (4 Phillips TLK 40 W/03) at 16 microwatts/cm2/nm (measured). | |
Outcomes | Duration of phototherapy. Use of exchange transfusion. Use of additional phototherapy. | |
Notes | Further data requested | |
Risk of bias | ||
Bias | Authors' judgement | Support for judgement |
Allocation concealment? | Low risk | A ‐ Adequate |